Table 1.
Summary of Studies and Clinical Outcomes
| First Author | Journal | Transplant | N | Age | AKI | RRT | ICU | Death | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Yang | Lancet Respir Med | - | 52 | 59.7 | 29.0% | 17.0% | 100.0% | 61.5% | 1 |
| Zhou | Lancet | - | 191 | 56 | 5.0% | 15.0% | 26.0% | 28.0% | 2 |
| Chen | BMJ | - | 113 | 68 | 25.0% | 2.6% | 82.0% | 100.0% | 3 |
| Chen | Lancet | - | 99 | 55.5 | 9.0% | 9.0% | 4.0% | 11.0% | 4 |
| Huang | Lancet | - | 41 | 49 | 7.0% | 7.0% | 31.0% | 15.0% | 5 |
| Grein | N Engl J Med | - | 53 | 64 | 6.0% | 0.0% | 64.0% | 13.0% | 6 |
| Cheng | Kidney Int | - | 701 | 63 | 5.1% | 2.0% | 10.4% | 16.1% | 7 |
| Cao | N Engl J Med | - | 199 | 58 | 4.5% | 4.5% | 22.0% | 22.0% | 8 |
| Guan | N Engl J Med | - | 1099 | 47 | 0.5% | 0.8% | 5.0% | 1.4% | 9 |
| Young | JAMA | - | 18 | 47 | 0.0% | 0.0% | 11.0% | 0.0% | 10 |
| Wang | Am J Nephrol | - | 116 | 54 | 0.0% | 0.0% | 9.4% | 6.0% | 11 |
| Richardson | JAMA | - | 2634 | 63 | 22.2% | 3.2% | 14.2% | 21.0% | 18 |
| Su | Kidney Int | - | 26 | 69 | 35.0% | 19.0% | NA | 100.0% | 16 |
| Banerjee | Kidney Int | + | 7 | 54 | 42.0% | 42.0% | 60.0% | 14.0% | 14 |
| Alberici | Kidney Int | + | 20 | 59 | 30.0% | 5.0% | 20.0% | 25.0% | 15 |
| Akalin | N Engl J Med | + | 36 | 60 | 16.0% | 16.0% | 27.0% | 28.0% | 19 |
| Gandolfini | Am J Transplant | + | 2 | 63 | 50.0% | 0.0% | 100.0% | 50.0% | 12 |
| Fernandez-Ruiz | Am J Transplant | + | 8 | 69 | NA | NA | 75.0% | 25.0% | 13 |
| Columbia Univ. | JASN | + | 15 | 51 | 40.0% | NA | 27.0% | 7.0% | 17 |
Abbreviations: AKI, acute kidney injury; ICU, intensive care unit; RRT, renal replacement therapy.